Ulcerative colitis, colorectal cancer and colonoscopic surveillance

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 8, 2005, Pages 881-885

  Moum, Bjørn ^a,c   Ekbom, Anders ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SO HF Fredrikstad Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; SALAZOSULFAPYRIDINE;

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CLINICAL TRIAL; COLON BIOPSY; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; DISEASE DURATION; DYSPLASIA; HUMAN; INCIDENCE; META ANALYSIS; MORTALITY; ONSET AGE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; POPULATION SURVEILLANCE; PREVALENCE; WORLD HEALTH;

EID: 23644462396     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520510023701     Document Type: Review

References (53)

1. Crohn BB, Rosenberg H. The sigmoidoscopy picture of chronic ulcerative colitis (non-specific). Am J Med Sci 1925; 170:220-8.
2. MacDougal IPM, Iond MD. The cancer risk in ulcerative colitis. Lancet 1964; 655-8.
3. Devroede GJ, Taylor WF, Saucer WG, Jackman RJ, Sticler GB. Cancer risk and life expectancy of children with ulcerative colitis. N Engl Med 1971;285:17-21.
4. Gyde SN, Prior P, Allan RN, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988;29:206-17.
5. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 1990;323:1228-33.
6. Langholz E, Munkholm P, Davidsen M, Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-51.
7. Karlen P, Løfberg R, Brostrøm O, Leijonmark CE, Hellers G, Persson PG. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterolol 1999;94:1047-52.
8. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48: 526-35.
9. Ekbom A, Kornfeld D. Sulphasalazine use as a preventive factor for colorectal cancer in ulcerative colitis patients [review]. Inflamm Bowel Dis 1996;2:276-8.
10. Morson BC, Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8:423-34.
11. Pohl C, Hombach A, Kruis W. Chronic inflammatory bowel disease and cancer. Hepato-Gastroenterol 2000;47: 57-70.
12. Gyde SN. Cancer in inflammatory bowel disease. Scand J Gastroenterol 1989;24:79-80.
13. Lynch DAF, Lobo AJ, Sobala GM, Dixon MF, Axon ATR. Failure of colonosopic surveillance in ulcerative colitis. Gut 1993;34:1075-80.
14. Hordijk ML, Shivananda S. Risk of cancer in inflammatory bowel disease: why are the results in the reviewed literature so varied? Scand J Gastroenterol 1989;24:70-4.
15. Sackett DL, Whelan G. Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis. Gastroenterology 1980;78:1632-5.
16. Lennard Jones JE, Morson BC, Ritchie JK, Williams C. Cancer surveillance in ulcerative colitis: experience over 15 years. Lancet 1983;ii:149-52.
17. Rosenstock E, Farmer RG, Petras R, Sivak MV, Rankin GB, Sullivan BH. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985;89:1342-6.
18. Manning AP, Bulgim OR, Dixon MF, Axon AT. Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut 1987;28:1489-94.
19. Rutegard J, Ahsgren L, Stenling R, Janunger KG. Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol 1988;23:139-45.
20. Nugent FW, Haggit RC, Gilpin PA. Cancer surveillance in ulcerative colitis. Gastroenterology 1991;8:423-34.
21. Fuson JA, Farmer RG, Hawk WA, Sullivan BH. Endoscopic surveillance for cancer in ulcerative colitis. Am J Gastroenterol 1980;73:120-6.
22. Korelitz BI. Considerations of surveillance, dysplasia and carcionma of the colon in the management of ulcerative colitis and Crohn's disease. Med Clin North Am 1990;74: 189-99.
23. Jonsson B, Ahsgren L, Andersson LO. Colorectal cancer surveillance in patients with ulcerative colitis. Br J Surg 1994;81:689-91.
24. Brostrøm O, Løfberg R, Ost A, Reichard H. Cancer surveillance of patients with longstanding ulcerative colitis: a clinical, endoscopical and histological study. Gut 1986;27: 1408-13.
25. Suzuki K, Muto T, Shinozak Mi. Results of cancer surveillance in ulcerative colitis. J Gastroenterol 1995;30:40-2.
26. Eisen GM, Chutkan R, Goldstein JL. Guidelines for colorectal cancer screening and surveillance. Gastrointest Endosc 2000;51:777-81.
27. Vilien M, Jørgensen MJ, Quyang Q. Colonic epithelial dysplasia or carcinoma in a regional group of patients with ulcerative colitis of more than 15 years' duration. J Intern Med 1991;230:259-63.
28. Griffiths AM, Sherman PM. Colonoscopic surveillance for cancer in ulcerative colitis: a critical review. J Pediatr Gastroenterol Nutr 1997;24:202-10.
29. Conell WR, Lennard Jones JE, Williams C, Talbot IC, Price AB, Wilkinson KH. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
30. Gyde SN. Screening for colorectal cancer in ulcerative colitis. Dubious benefits and high costs. Gut 1990;31: 1089-92.
31. Lashner BA, Kane SV, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis. Historical cohort. Am J Gastroenterol 1990;85:1083-7.
32. Collins RH, Feldman, Fortran JS. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 1987;316:1654-8.
33. Axon ATR. Cancer surveillance in ulcerative colitis: a time for reappraisal. Gut 1994;35:587-9.
34. Woolrich AJ, Da Silva MD, Korelitz BI. Surveillance in the routine management of ulcerative colitis: the predictive value of low grade dysplasia. Gastroenterology 1992;103:431-8.
35. Delco F, Sonnenberg A. A decision analysis of surveillance for colorectal cancer in ulcerative colitis. Gut 2000;46:500-6.
36. Provenzales D, Wong JB, Onken JE. Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. Am J Gastroenetrol 1997;93:872-80.
37. Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A. Is colonoscopic surveillance reducing colorectal cancer in ulcerative colitis? Gut 1998;42:711-4.
38. Choi PM, Nugent FW, Schoetz DJ, Silverman ML, Haggitt RC. Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993;105: 418-24.
39. Vemulap R, Lance P, editors. Cancer surveillance in ulcerative colitis: more of the same or progress? Gastroenterolgy 1995;107:1196-9.
40. Helper DJ, Rex DK. Inflammatory bowel disease. Endsocopy 2001;33:143-6.
41. Eaden J, Ward B, Mayberry J. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000;51:123-8.
42. Gyde SN, Prior P, Allan RN, Stevens A, Jewell DP, Truelove SC, et al. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988;29: 206-17.
43. Devroede GJ, Taylor FW, Sauer WG. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971;285:17-21.
44. Greenstein AJ, Sachar DB, Smith H, Pucillo A, Papatestas AE, Kreel L, et al. Cancer in universal and leftsided colitis: factors determining risk. Gastroenterology 1979;77: 290-4.
45. Wandall E, Damkier P, Møller Pedersen F, Wilson B, Schaffalitzky de Muckadell OB. Survival and incidence of colorectal cancer in patients with ulcerative colitis in Funen County diagnosed between 1973 and 1993. Scand J Gastroenterol 2000;35:312-7.
46. Moody GA, Jayanthi V, Probert H, Mac Kay H, Mayberry JF. Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 1996;8:1179-83.
47. Inadomi JM. Cost-effectiveness of colorectal cancer surveillance in ulcerative colitis. Scand J Gastroenterol 2003;38 Suppl 237:17-21.
48. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami H-O. Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 1994;107: 117-20.
49. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharamacol Ther 2000;14: 145-53.
50. Lashner BS, Heidenreich PA, Su GL, Kance SV, Hanauer SB. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. Gastroenterology 1989;97:255-9.
51. Bernstein CN, Eaden J, Hillary Steihart A, Munkholm P, Gordon PH. Cancer prevention in inflammatory bowel disease and the chemopropylactic potential of 5-aminosalicylic acid. Inflamm Bowel Dis 2002;8:356-61.
52. Nuako KW, Alhquist DA, Mahoney DW, et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case control study. Gastroenterology 1998;115: 1079-83.
53. Shetty K, Rybicki L, Brzezinzki A, Carey W, Lashner B. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 1999;94:1643-9.